Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-11

FDA Approved: DESLORATADINE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for desloratadine filed by Bionpharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desloratadine (desloratadine)

Snippet

SUPPL AP for DESLORATADINE (DESLORATADINE)